Mode
Text Size
Log in / Sign up

Microbial exopolysaccharides improve intestinal health and gut microbiome modulation in 28 in vivo studiesMicrobial exopolysaccharides may improve gut health and intestinal barrier integrity

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the potential of microbial exopolysaccharides to improve intestinal health and gut microbiome modulation.

This systematic review synthesizes findings from 28 in vivo studies regarding the impact of microbial exopolysaccharides (EPS) on intestinal health. The review focuses on several key physiological and biochemical markers, including gut microbiome composition, intestinal epithelium integrity, and inflammatory biomarkers.

The synthesis indicates that EPS are associated with modulated gut microbiomes and enhanced intestinal epithelium integrity. Furthermore, the review notes that EPS are linked to altered inflammatory biomarkers, affected colonic morphology, and increased short-chain fatty acid (SCFA) production. These findings suggest that EPS may function as bioactive macromolecules with potential benefits for intestinal health.

Limitations noted by the authors include a limited consideration of the role of EPS during small intestinal digestion. Clinical application of these findings is currently limited by the nature of the evidence and the specific focus on in vivo models. The potential of EPS as bioactive macromolecules for improving intestinal health warrants further investigation.

Your gut is more than just a digestive tube; it is a complex environment where your immune system and microbiome work together. Researchers are looking closely at microbial exopolysaccharides, which are large molecules produced by certain microbes. These molecules might play a significant role in keeping your gut healthy.

A review of 28 in vivo studies found that these substances can change the gut microbiome and strengthen the intestinal lining. They also appeared to increase the production of short-chain fatty acids, which are important for gut health, and altered markers of inflammation. These findings suggest that these molecules could be important for maintaining the physical structure of the colon.

While these results are promising, the evidence is still early. The current research does not fully explore how these substances behave during digestion in the small intestine. Because the data comes from a variety of studies, more research is needed to understand exactly how they work in the human body.

What this means for you:
Microbial exopolysaccharides may improve gut health by strengthening the intestinal lining and increasing healthy fatty acids.

Common questions

What are microbial exopolysaccharides?

These are large molecules, called bioactive macromolecules, produced by certain microbes. They are being studied because they may have a positive impact on intestinal health and the gut microbiome.

How do these substances affect the gut?

The review of 28 studies found that these molecules can modulate the gut microbiome, enhance the integrity of the intestinal lining, and increase the production of short-chain fatty acids.

Are there any limitations to these findings?

The current research has a limited look at how these substances behave during digestion in the small intestine. More study is needed to fully understand their role.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Microbial exopolysaccharides (EPS) are secondary metabolites produced and secreted by microorganisms during fermentation. Their structure and physicochemical properties depend on the microbial strain and growth conditions, making them highly versatile for application in the food industry. Current investigations have expanded to include their use as a bioactive compound, providing health benefits to the host without the introduction of live microorganisms, as in the case with probiotics. This systematic review analyzed 28 in vivo studies to assess the effects of EPS on intestinal health. Evidence suggests that EPS modulates the gut microbiome, enhances intestinal epithelium integrity, alters inflammatory biomarkers, affects colonic morphology, and increases short-chain fatty acid (SCFA) production. Overall, this systematic review primarily focuses on colonic health, with limited consideration of the role of EPS during small intestinal digestion. The findings support the potential of microbial exopolysaccharides as bioactive macromolecules that may improve intestinal health. This systematic review has been registered with the International Prospective Register of Systematic Reviews database (PROSPERO) (ID: CRD420261292367).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.